Tuesday, January 14, 2025 1/14/2025

Characterization of Keloid Specific Exosomes and Determination of Exosomal Critical Signaling Pathways in the Keloid Microenvironment

Award Number: K08GM128156
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

Group Awards By:

View Award Abstract

Project Summary/Abstract: There are more than 11 million people in the world with keloids and more than 425,000 associated clinic visits, yearly, in the United States. Keloids are benign fibroproliferative tumors which cause pain, pruritus, emotional distress and loss of function. Current therapies are unsatisfactory with unacceptably high recurrence rates, mainly because of an incomplete understanding of keloid pathogenesis. Fibroblasts are a key player in keloid pathogenesis, but the drivers are unknown. Keloid disease is influenced by aberrant signaling pathways. However, no clear signaling pathway has been identified. Exosomes mediate cell-cell communication, exercising primary physiological and pathophysiological function. Exosomal cargo, such as microRNAs (miRNAs), regulate cellular function. Our group identified RAB27, important for exosome secretion, as being differentially hypomethylated in keloid compared to normal skin. Our group has isolated keloid-specific exosomes. To date, there are no published studies on keloid exosomes or the contribution of RAB27 methylation on exosome function. We propose to test the central hypothesis that exosomes communicate critical signaling events in the keloid microenvironment mediated by RAB27 gene methylation. Aim 1: To determine the effect of RAB27 methylation on keloid exosome production and miRNA cargo profiles. Hypotheses: (1) Keloid exosomal production correlates with RAB27 gene methylation. (2) Keloid exosomal cargo miRNA expression profiles correlates with RAB27 gene methylation. (3) Keloid exosome miRNA’s putative target genes lie within pathways essential for wound healing and/or fibrosis. Aim 2: To determine the effects of keloid exosomes on the keloid microenvironment. Hypothesis: Keloid fibroblast exosomes compared to normal fibroblast exosomes will cause pro-fibrotic phenotype changes in normal fibroblasts. Aim 3: To determine the effect of keloid exosomes on scar formation in vivo. Hypothesis: Exosomes generated in aim 1 and tested in aim 2 will increase scar formation in a rabbit ear scar model. Significance: This project will lead to an enhanced understanding of keloid pathogenesis and the potential for exosome-based therapy. Innovation: (i) rational progression from preliminary data supporting the novel role of exosomes in keloid pathogenesis; (ii) investigating the influence of RAB27 methylation on the function and production of keloid exosomes would suggest a mechanistic basis for novel epigenetic biomarkers;(iii) using unique resources which includes fibroblast cell lines from primary untreated keloid (25) and matched normal skin (25) from a multi-ethnic group of patients and an in vivo animal model allow for the pragmatic translational application of results; (iv) entirely new field of keloid investigation. In summary, this project, mentoring and career development plan will position, Lamont R Jones, MD, MBA, to become an independent clinician scientist and leader in keloid pathogenesis.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	HENRY FORD HEALTH SYSTEM	1 FORD PL	DETROIT	MI	48202	WAYNE	USA	Biomedical Research and Research Training	000	5	4/16/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $179,280 )
2022	2022	HENRY FORD HEALTH SYSTEM	1 FORD PL	DETROIT	MI	48202	WAYNE	USA	Biomedical Research and Research Training	000	5	7/7/2022	NON-COMPETING CONTINUATION	$179,280
														Subtotal = $179,280

Issue Date FY: 2021 ( Subtotal = $179,280 )
2021	2021	HENRY FORD HEALTH SYSTEM	1 FORD PLACE	DETROIT	MI	48202	WAYNE	USA	Biomedical Research and Research Training	000	4	7/2/2021	NON-COMPETING CONTINUATION	$179,280
														Subtotal = $179,280

Issue Date FY: 2020 ( Subtotal = $178,387 )
2020	2020	HENRY FORD HEALTH SYSTEM	1 FORD PLACE	DETROIT	MI	48202	WAYNE	USA	Biomedical Research and Research Training	000	3	7/17/2020	NON-COMPETING CONTINUATION	$178,387
														Subtotal = $178,387

Issue Date FY: 2019 ( Subtotal = $178,387 )
2019	2019	HENRY FORD HEALTH SYSTEM	1 FORD PLACE	DETROIT	MI	48202	WAYNE	USA	Biomedical Research and Research Training	000	2	7/17/2019	NON-COMPETING CONTINUATION	$178,387
														Subtotal = $178,387

Issue Date FY: 2018 ( Subtotal = $178,387 )
2018	2018	HENRY FORD HEALTH SYSTEM	1 FORD PLACE	DETROIT	MI	48202	WAYNE	USA	Biomedical Research and Research Training	000	1	7/11/2018	NEW	$178,387
														Subtotal = $178,387

Grand Total All Awards = $893,721

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Characterization of Keloid Specific Exosomes and Determination of Exosomal Critical Signaling Pathways in the Keloid Microenvironment

Award Number: K08GM128156

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer